1219319

Teva Pharmaceuticals USA, Inc — FEI 3003092769

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 29, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Parsippany, NJ (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)

Citations

IDCFRDescription
21360FDCA 505-1(f)(4)Failure to comply with REMS Implementation System